This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
The results of recent cancer clinical trials should be interpreted with caution.
This page is a summary of: Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results?, Journal of Clinical Oncology, April 2021, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.20.03262.
You can read the full text:
The following have contributed to this page
Journal of Alzheimer s Disease
In clinical trials and research generally, there has been an increasing shift towards remote clinical assessment and decentralized trials, to support patient centricity goals around improved access...
Kidney and Blood Pressure Research
Complements related disease
Journal of Alzheimer s Disease
Recent innovative non-pharmacological interventions and neurostimulation devices have shown potential for application in the treatment of Alzheimer’s disease. These include photobiomodulation thera...
